The global platelet rich plasma market is expected to hit $400 million by 2023, growing at a 13.3 percent compound annual growth rate, according to a Qurate Business Intelligence report.
Biologics
The global orthopedic biomaterials market is expected to grow at a 7 percent compound annual growth rate between 2018 and 2022, according to a Technavio report.
Bioventus launched its Osteomatrix+ bone graft for various spine and orthopedic applications.
Orthopedic fixation company Ossio received FDA 510(k) clearance for its Ossiofiber Bone Pin Family.
Marco Rodriguez, MD, founder of Baton Rouge, La.-based International Spine Institute, is using regenerative stem cell therapies as an alternative to spinal surgery.
Advertisement
Generex Biotechnology Corp. signed a letter to purchase Medisource Partners, an FDA-registered distributor.
SpinalCyte received a new Australian patent related to its fibroblast technology.
DiscGenics' injectable disc cell therapy, IDCT, passed the initial safety review of its first-in-human trial for moderate degenerative disc disease treatment.
JRF Ortho provides allograft joint repair solutions.
The FDA granted StemCyte permission to proceed with its phase 2 investigational new drug application for the Allogenic Human Leukocyte Antigen-Matched Umbilical Cord Blood Mononuclear Stem Cells (MC001).